INIS
aging
8%
antibodies
9%
arsenic
10%
arthritis
77%
assessments
8%
biological markers
37%
blood
9%
bone marrow
10%
bones
25%
brain
11%
cancer
21%
cell cultures
7%
comparative evaluations
28%
concentration
32%
control
20%
data
19%
diabetes mellitus
17%
diseases
43%
drugs
13%
evaluation
12%
fibrosis
8%
genes
27%
humans
17%
in vivo
7%
inflammation
20%
insulin
18%
interferon
17%
interleukins
10%
levels
39%
medicine
11%
men
7%
metastases
9%
methotrexate
7%
nmr imaging
14%
oxidation
20%
pathogenesis
7%
patients
100%
peptides
14%
phenotype
11%
power
8%
proteins
14%
reviews
17%
risks
17%
sensitivity
17%
therapy
18%
tissues
8%
tumors
23%
values
14%
vitamin c
14%
women
15%
Medicine and Dentistry
Biological Marker
13%
Cardiac Magnetic Resonance Imaging
10%
Cardiovascular Risk
5%
Chromogranin A
7%
Cytokine
5%
Diagnosis
5%
Disease
12%
Fibrosis
6%
Gene Expression
9%
Interferon
7%
Interferon Type I
5%
Interleukin 7
7%
Maturity Onset Diabetes of the Young
7%
Musculoskeletal Disease
7%
Neuroendocrine Tumor
7%
Patient with Type 2 Diabetes
7%
Rheumatic Disease
7%
Rheumatoid Arthritis
41%
Stromal Cell
7%
Systematic Review
9%
T Cell
7%
T Cell Subset
7%
TNF Inhibitor
7%
Keyphrases
Arsenic Trioxide
7%
Biochemical Parameters
8%
Bone Turnover
8%
Cancer Cells
5%
Chromogranin A
10%
Diagnostic Power
7%
Early Rheumatoid Arthritis
7%
Gene Expression
5%
Human Mesenchymal Stem Cells (hMSCs)
7%
Interleukin-7 (IL-7)
7%
Mesenchymal Stromal Cells
7%
Neuroendocrine Tumor
10%
Osteocalcin
10%
Oxidative Stress
5%
Rheumatoid Arthritis
26%
Rheumatoid Arthritis Patients
6%
Traditional Cardiovascular Risk Factors
5%
Type 2 Diabetes Mellitus (T2DM)
8%
Type 2 Diabetic Patients
14%
Vitamin C
10%
Vitamin D
5%